Predicate |
Object |
contentType |
Journal Article|Review |
endingPage |
637 |
issn |
0733-8651 |
issueIdentifier |
4 |
pageRange |
629-637 |
publicationName |
Cardiology clinics |
startingPage |
629 |
bibliographicCitation |
Wiviott SD. Intensity of antiplatelet therapy in patients with acute coronary syndromes and percutaneous coronary intervention: the promise of prasugrel? Cardiol Clin. 2008 Nov;26(4):629–37. doi: 10.1016/j.ccl.2008.07.003. PMID: 18929236. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7794e910d6a5d9ee3fff04a505b619b8 |
date |
200811 |
identifier |
https://pubmed.ncbi.nlm.nih.gov/18929236 https://doi.org/10.1016/j.ccl.2008.07.003 |
isPartOf |
https://portal.issn.org/resource/ISSN/0733-8651 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2806 |
language |
English |
source |
https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/ |
title |
Intensity of Antiplatelet Therapy in Patients with Acute Coronary Syndromes and Percutaneous Coronary Intervention: the Promise of Prasugrel? |
discusses |
http://id.nlm.nih.gov/mesh/M0017012 http://id.nlm.nih.gov/mesh/M0021526 http://id.nlm.nih.gov/mesh/M0155432 http://id.nlm.nih.gov/mesh/M0001864 http://id.nlm.nih.gov/mesh/M0021371 http://id.nlm.nih.gov/mesh/M000603803 http://id.nlm.nih.gov/mesh/M0016884 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12210218 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7065 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918456 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9412 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8198 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11015 |